Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab

BACKGROUND: The purpose of this study was to determine if eyes with diabetic macular edema (DME) unresponsive to ranibizumab or bevacizumab would benefit from conversion to aflibercept. METHODS: This study was conducted as a retrospective chart review of subjects with DME unresponsive to ranibizumab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Ophthalmol
Main Authors: Lim, Laurence S, Ng, Wei Yan, Mathur, Ranjana, Wong, Doric, Wong, Edmund YM, Yeo, Ian, Cheung, Chui Ming Gemmy, Lee, Shu Yen, Wong, Tien Yin, Papakostas, Thanos D, Kim, Leo A
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4577250/
https://ncbi.nlm.nih.gov/pubmed/26396494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S81523
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados